AXIM — Axim Biotechnologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Axim Biotechnologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.753	0.457	0.453	0.047	0.156
Net Total Accounts Receivable
Net Total Receivables	0.321	—	—	—	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.64	0.713	0.637	0.104	0.156
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.002	0.235	0.194	0.114	0.361
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1.69	11.3	5.32	4.21	4.12
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.4	1.5	2.58	3.39	5.98
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	8.45	9.75	7.66	9.04	11.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-6.76	1.57	-2.34	-4.83	-7.66
Total Liabilities & Shareholders' Equity	1.69	11.3	5.32	4.21	4.12
Total Common Shares Outstanding
Total Preferred Shares Outstanding